The program is subject to change.


Abstract Book published online in Tissue Engineering part A

Detailed Program

The program is subject to change. Last update 30 June 2022

Conference Book

Detailed Poster List

The list is subject to change. Last update 25 June 2022

Poster sessions will be held on Tuesday, Wednesday and Thursday.
Within each symposium podium presentations and poster session will take place on the same day.

Symposia Program – timetable

Symposia list

  • S01 3D in vitro tissue-engineered cancer/disease models – Session I
  • S02 3D in vitro tissue-engineered cancer/disease models – Session II
  • S03 3D printing of bionic organs – how far are we from clinical application?
  • S04 3D Writing Within Suspension Media for Tissue Engineering and In Vitro Modeling
  • S05 Additive manufacturing in tissue repair: current status and obstacles toward a daily clinical practice
  • S06 Advanced Biotechnology and Biofabrication approaches for soft tissue engineering and in vitro models: the ENLIGHT and BIRDIE perspective
  • S07 Advances in cardiac tissue engineering: in vitro platforms and in vivo regeneration
  • S08 Antimicrobial biomaterials for bone regeneration
  • S09 Biobanking – indispensable support for the development of regenerative medicine
  • S10 Biofabricated Tissues and Organs for Clinical Impact
  • S11 Biofabrication using extrinsic fields
  • S12 Biofabrication with light-based technologies and high-definition printing
  • S13 Biofunctionalized surfaces for cellular and tissue engineering
  • S14 Biological testing of 3D-printed biomaterials – towards updated norms
  • S15 Biologically inspired and Engineered disease models
  • S16 Biomaterials from nature based on extracellular matrices: engineering, repopulation and regenerative potential
  • S17 Biomaterials, Stem Cells and Ostogenesis, Immunogenicity and Biocompatibility
  • S18 Biomedical applications of MXene based next generation nanomaterials
  • S19 Biomimetic Approaches to Cardiovascular Regeneration: how and why?
  • S20 Biomimetic in vitro models for bone regeneration and cancer pathologies
  • S21 Biophysical Therapies – External energy to push internal regeneration
  • S22 Bringing together state-of-the-art quantitative biology and machine learning-based modeling for controlling and predicting cell and cell population phenotype in the context of regenerative medicine
  • S23 Can we bioengineer tissues using artificial cells?
  • S24 Cell-rich constructs for tissue engineering
  • S25 Cellular senescence in tissue damage and regeneration
  • S26 Combined Korea-EU Symposium: “Bone from fat: Two distinct 17-18 year journeys in bone regeneration with adipose stromal/stem cells”
  • S27 Combined therapies for severely infected wounds accompanied with both heavy soft and hard tissue losses
  • S28 Emerging and future technologies for peripheral nerve regeneration
  • S29 Engineered viscoelasticity in cell and tissue engineering
  • S30 European regional platforms for TERM – Update
  • S31 Extracellular vesicles – next generation tool for diagnostics and regenerative medicine
  • S32 Extracellular vesicles for soft tissue repair
  • S33 From Bench-to-Bedside: Translating 3D Printing Applications in Tissue Engineering and Regenerative Medicine
  • S34 Gene therapy approaches in tissue engineering
  • S35 Giving meaning to early tissue damage responses in regeneration
  • S36 Glycomodulation Approaches in Tissue Engineering
  • S37 Human Organoids for Musculoskeletal Tissues
  • S38 Injectable biomaterials for cell-instructive matrix cues
  • S39 Injectable composite hydrogels as scaffolds and drug delivery systems for tissue engineering
  • S40 Injectable scaffolds in tissue engineering
  • S41 Mesenchymal Stem / Stromal Cells – from basic research through clinical studies to registered products
  • S42 Microphysiological models as powerful preclinical tools
  • S43 Multifunctional biomaterials supporting bone regeneration
  • S44 Nano Magnetic platforms – an attractive opportunity for advancing TERM products to the clinic
  • S45 Nature bioinspired biomaterials and strategies for TERM
  • S46 New developments of regenerative and tissue modeling products
  • S47 New insights underlying mesenchymal stem cell-mediated bone regeneration
  • S48 Next Generation Biomaterials of Stem Cell Culture and Differentiation for Stem Cell Therapy
  • S49 Novel strategies to assess cellular response to biomaterials
  • S50 One health, one medicine: What Veterinary regenerative medicine can teach us
  • S51 Perspectives and Challenges in Bioengineering Dynamic Hydrogels for Regenerative Medicine
  • S52 Perspectives For Future Innovation in Tendon repair (P4 FIT)
  • S53 Prospects and Challenges in Biological Therapies for Tendon Regeneration
  • S54 Regulation of cell phenotype in osteochondral tissues: towards RNA therapy for bone and cartilage repair
  • S55 REMODELing the Future: next generation of organoid models for biomedicine
  • S56 Skin wound healing in 2022: where basic science meets clinical needs
  • S57 Supramolecular synthetic scaffolds: from concept to design and application
  • S59 The role of multifunctional nanomaterials in new tissue regeneration strategies
  • S60 Tissue engineering and regenerative medicine in Czech Republic
  • S61 Tissue Engineering in Microgravity for Health in Space and on Earth
  • S62 Tissue regeneration by integration of bioinspired materials
  • S63 Towards automated technologies for organoid-based tissue biomanufacturing
  • S64 Understanding and preventing early inflammatory events that lead to development of osteoarthritis
  • S65 Vascularization for Tissue Engineering and Regenerative Medicine
  • S66 Wanted: Dead or Alive? Quantitative microscopy of spheroid and organoid tissues
  • S67 We’ve got your back: the challenges and success of advanced regenerative treatments for intervertebral disc regeneration
  • S68 Human brain organoids versus assembloids approach for neurodevelopmental studies

Poster session list

Tuesday, 28th June 2022

  • PS01 3D in vitro tissue-engineered cancer/disease models – Session I
  • PS02 3D in vitro tissue-engineered cancer/disease models – Session II
  • PS03 3D printing of bionic organs – how far are we from clinical application?
  • PS04 3D Writing Within Suspension Media for Tissue Engineering and In Vitro Modeling
  • PS06 Advanced Biotechnology and Biofabrication approaches for soft tissue engineering and in vitro models: the ENLIGHT and BIRDIE perspective
  • PS07 Advances in cardiac tissue engineering: in vitro platforms and in vivo regeneration
  • PS08 Antimicrobial biomaterials for bone regeneration
  • PS09 Biobanking – indispensable support for the development of regenerative medicine
  • PS12 Biofabrication with light-based technologies and high-definition printing
  • PS16 Biomaterials from nature based on extracellular matrices: engineering, repopulation and regenerative potential
  • PS17 Biomaterials, Stem Cells and Ostogenesis, Immunogenicity and Biocompatibility
  • PS19 Biomimetic Approaches to Cardiovascular Regeneration: how and why?
  • PS22 Bringing together state-of-the-art quantitative biology and machine learning-based modeling for controlling and predicting cell and cell population phenotype in the context of regenerative medicine
  • PS25 Cellular senescence in tissue damage and regeneration
  • PS33 From Bench-to-Bedside: Translating 3D Printing Applications in Tissue Engineering and Regenerative Medicine
  • PS49 Novel strategies to assess cellular response to biomaterials
  • PS64 Understanding and preventing early inflammatory events that lead to development of osteoarthritis
  • PS68 Human brain organoids versus assembloids approach for neurodevelopmental studies

Wednesday, 29th June 2022

  • PS10 Biofabricated Tissues and Organs for Clinical Impact
  • PS11 Biofabrication using extrinsic fields
  • PS13 Biofunctionalized surfaces for cellular and tissue engineering
  • PS15 Biologically inspired and Engineered disease models
  • PS20 Biomimetic in vitro models for bone regeneration and cancer pathologies
  • PS24 Cell-rich constructs for tissue engineering
  • PS27 Combined therapies for severely infected wounds accompanied with both heavy soft and hard tissue losses
  • PS28 Emerging and future technologies for peripheral nerve regeneration
  • PS30 European regional platforms for TERM – Update
  • PS31 Extracellular vesicles – next generation tool for diagnostics and regenerative medicine
  • PS32 Extracellular vesicles for soft tissue repair
  • PS37 Human Organoids for Musculoskeletal Tissues
  • PS38 Injectable biomaterials for cell-instructive matrix cues
  • PS41 Mesenchymal Stem / Stromal Cells – from basic research through clinical studies to registered products
  • PS43 Multifunctional biomaterials supporting bone regeneration
  • PS47 New insights underlying mesenchymal stem cell-mediated bone regeneration
  • PS48 Next Generation Biomaterials of Stem Cell Culture and Differentiation for Stem Cell Therapy
  • PS56 Skin wound healing in 2022: where basic science meets clinical needs
  • PS62 Tissue regeneration by integration of bioinspired materials

Thursday, 30th June 2022

  • PS05 Additive manufacturing in tissue repair: current status and obstacles toward a daily clinical practice
  • PS14 Biological testing of 3D-printed biomaterials – towards updated norms
  • PS18 Biomedical applications of MXene based next generation nanomaterials
  • PS21 Biophysical Therapies – External energy to push internal regeneration
  • PS26 Combined Korea-EU Symposium: “Bone from fat: Two distinct 17-18 year journeys in bone regeneration with adipose stromal/stem cells”
  • PS29 Engineered viscoelasticity in cell and tissue engineering
  • PS34 Advanced therapy approaches in tissue engineering
  • PS35 Giving meaning to early tissue damage responses in regeneration
  • PS36 Glycomodulation Approaches in Tissue Engineering
  • PS39 Injectable composite hydrogels as scaffolds and drug delivery systems for tissue engineering
  • PS40 Injectable scaffolds in tissue engineering
  • PS42 Microphysiological models as powerful preclinical tools
  • PS45 Nature bioinspired biomaterials and strategies for TERM
  • PS46 New developments of regenerative and tissue modeling products
  • PS50 One health, one medicine: What Veterinary regenerative medicine can teach us
  • PS51 Perspectives and Challenges in Bioengineering Dynamic Hydrogels for Regenerative Medicine
  • PS52 Perspectives For Future Innovation in Tendon repair (P4 FIT)
  • PS53 Prospects and Challenges in Biological Therapies for Tendon Regeneration
  • PS54 Regulation of cell phenotype in osteochondral tissues: towards RNA therapy for bone and cartilage repair
  • PS55 REMODELing the Future: next generation of organoid models for biomedicine
  • PS57 Supramolecular synthetic scaffolds: from concept to design and application
  • PS58 TERMIS-EU SYIS and yESAO joint symposium
  • PS59 The role of multifunctional nanomaterials in new tissue regeneration strategies
  • PS60 Tissue engineering and regenerative medicine in Czech Republic
  • PS61 Tissue Engineering in Microgravity for Health in Space and on Earth
  • PS63 Towards automated technologies for organoid-based tissue biomanufacturing
  • PS65 Vascularization for Tissue Engineering and Regenerative Medicine
  • PS66 Wanted: Dead or Alive? Quantitative microscopy of spheroid and organoid tissues
  • PS67 We’ve got your back: the challenges and success of advanced regenerative treatments for intervertebral disc regeneration

Sponsors

PLATINUM

GOLD

SILVER

BRONZE